当前位置:
X-MOL 学术
›
Asia Pac. J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Potential benefit of dose-escalated stereotactic body radiation therapy using CyberKnife for early-stage primary lung cancer
Asia-Pacific Journal of Clinical Oncology ( IF 1.9 ) Pub Date : 2022-09-09 , DOI: 10.1111/ajco.13842 Shou Watanabe 1 , Hideya Yamazaki 1, 2 , Takuya Kimoto 1 , Hiroya Shiomi 1 , Kei Yamada 1 , Gen Suzuki 1
Asia-Pacific Journal of Clinical Oncology ( IF 1.9 ) Pub Date : 2022-09-09 , DOI: 10.1111/ajco.13842 Shou Watanabe 1 , Hideya Yamazaki 1, 2 , Takuya Kimoto 1 , Hiroya Shiomi 1 , Kei Yamada 1 , Gen Suzuki 1
Affiliation
The study aimed to evaluate the efficacy and safety of dose-escalated stereotactic body radiotherapy (SBRT) for primary lung cancer.
中文翻译:
使用 CyberKnife 进行剂量递增立体定向放疗治疗早期原发性肺癌的潜在益处
该研究旨在评估剂量递增立体定向体部放疗 (SBRT) 治疗原发性肺癌的疗效和安全性。
更新日期:2022-09-09
中文翻译:
使用 CyberKnife 进行剂量递增立体定向放疗治疗早期原发性肺癌的潜在益处
该研究旨在评估剂量递增立体定向体部放疗 (SBRT) 治疗原发性肺癌的疗效和安全性。